NK cell activation, as assessed by either gain of CD107a or loss of CD16, or the fold increase in the frequency of CD3−CD56+CD107a+ NK cells was greater in RA compared with SLE (Fig. 3B). The gene discussed is FCGR3A; the disease is rheumatoid arthritis.